Follow
Cassandra Kerr
Cassandra Kerr
Verified email at ccf.org
Title
Cited by
Cited by
Year
Dynamics of clonal evolution in myelodysplastic syndromes
H Makishima, T Yoshizato, K Yoshida, MA Sekeres, T Radivoyevitch, ...
Nature genetics 49 (2), 204-212, 2017
4272017
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
L Palomo, M Meggendorfer, S Hutter, S Twardziok, V Ademā, I Fuhrmann, ...
Blood, The Journal of the American Society of Hematology 136 (16), 1851-1862, 2020
1282020
Personalized prediction model to risk stratify patients with myelodysplastic syndromes
A Nazha, R Komrokji, M Meggendorfer, X Jia, N Radakovich, J Shreve, ...
Journal of Clinical Oncology 39 (33), 3737, 2021
1052021
Genomic determinants of chronic myelomonocytic leukemia
BJ Patel, B Przychodzen, S Thota, T Radivoyevitch, V Visconte, ...
Leukemia 31 (12), 2815-2823, 2017
972017
Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)
SR Sanikommu, MJ Clemente, P Chomczynski, MG Afable, A Jerez, ...
Leukemia & lymphoma 59 (2), 416-422, 2018
942018
Rational management approach to pure red cell aplasia
SK Balasubramanian, M Sadaps, S Thota, M Aly, BP Przychodzen, ...
Haematologica 103 (2), 221, 2018
712018
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes
Y Nagata, R Zhao, H Awada, CM Kerr, I Mirzaev, S Kongkiatkamon, ...
Blood, The Journal of the American Society of Hematology 136 (20), 2249-2262, 2020
672020
Origins of myelodysplastic syndromes after aplastic anemia
E Negoro, Y Nagata, MJ Clemente, N Hosono, W Shen, A Nazha, ...
Blood, The Journal of the American Society of Hematology 130 (17), 1953-1957, 2017
662017
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes
A Nazha, K Al-Issa, BK Hamilton, T Radivoyevitch, AT Gerds, S Mukherjee, ...
Leukemia 31 (12), 2848-2850, 2017
642017
Consequences of mutant TET2 on clonality and subclonal hierarchy
CM Hirsch, A Nazha, K Kneen, ME Abazeed, M Meggendorfer, ...
Leukemia 32 (8), 1751-1761, 2018
632018
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes
Y Nagata, H Makishima, CM Kerr, BP Przychodzen, M Aly, A Goyal, ...
Nature communications 10 (1), 5386, 2019
572019
Genomic biomarkers to predict resistance to hypomethylating agents in patients with myelodysplastic syndromes using artificial intelligence
A Nazha, MA Sekeres, R Bejar, MJ Rauh, M Othus, RS Komrokji, ...
JCO precision oncology 3, 1-11, 2019
552019
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia
S Lundgren, MAI Keränen, M Kankainen, J Huuhtanen, G Walldin, ...
Leukemia 35 (5), 1365-1379, 2021
522021
Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes
Y Nagata, S Narumi, Y Guan, BP Przychodzen, CM Hirsch, H Makishima, ...
Blood, The Journal of the American Society of Hematology 132 (21), 2309-2313, 2018
522018
A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms
Y Guan, AD Tiwari, JG Phillips, M Hasipek, DR Grabowski, S Pagliuca, ...
Blood cancer discovery 2 (2), 146-161, 2021
452021
Complex landscape of alternative splicing in myeloid neoplasms
CE Hershberger, DC Moyer, V Adema, CM Kerr, W Walter, S Hutter, ...
Leukemia 35 (4), 1108-1120, 2021
442021
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
C Saygin, C Hirsch, B Przychodzen, MA Sekeres, BK Hamilton, ...
Blood cancer journal 8 (1), 4, 2018
432018
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia
H Awada, A Durmaz, C Gurnari, A Kishtagari, M Meggendorfer, CM Kerr, ...
Blood, The Journal of the American Society of Hematology 138 (19), 1885-1895, 2021
422021
Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide
E Negoro, T Radivoyevitch, C Polprasert, V Adema, N Hosono, ...
Leukemia 30 (12), 2405-2409, 2016
402016
Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia
H Awada, Y Nagata, A Goyal, MF Asad, B Patel, CM Hirsch, ...
Blood advances 3 (3), 339-349, 2019
392019
The system can't perform the operation now. Try again later.
Articles 1–20